Nasdaq · Healthcare
Pennant Group, Inc. (PNTG)
As-reported financials and recent SEC filings for Pennant Group, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$947.7M
Net income
$29.6M
Net margin
3.1%
Diluted EPS
$0.84
ROE
7.9%
P/E (TTM)
41.8×
Market cap
$1.25B
Debt / equity
0.5×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $947.7M | $695.2M | $544.9M | $473.2M | $439.7M |
| Gross profit | — | — | — | — | — |
| Operating income | $51.9M | $38.1M | $25.2M | $12.7M | $4.7M |
| Net income | $29.6M | $22.6M | $13.4M | $6.6M | $2.7M |
| Diluted EPS | $0.84 | $0.70 | $0.44 | $0.22 | $0.09 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-05-27
View on EDGAR →1442026-05-22
View on EDGAR →8-K2026-05-20
View on EDGAR →1442026-05-14
View on EDGAR →10-Q2026-05-06
View on EDGAR →8-K2026-05-06
View on EDGAR →42026-04-17
View on EDGAR →42026-04-17
View on EDGAR →Go deeper on PNTG
Search Pennant Group, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.